UCB SA

47
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BE0003739530
EUR
253.90
6.5 (2.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
UCB SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,822.00
1,163.00
441.00
511.00
1,226.00
878.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
302.00
140.00
-247.00
-121.00
116.00
-140.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2,163.00
1,082.00
617.00
1,045.00
1,490.00
1,011.00
Cash Flow from Investing Activities
-389.00
282.00
-440.00
-1,580.00
-487.00
-2,228.00
Cash Flow from Financing Activities
-1,086.00
-658.00
-164.00
144.00
-1,056.00
1,247.00
Net Cash Inflow / Outflow
678.00
712.00
2.00
-385.00
-60.00
15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-10.00
6.00
-11.00
6.00
-7.00
-15.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of UCB SA
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
1822
-6.924
1,828.00
26414.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
302
-1.338
303.00
22671.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
2163
-6.347
2,169.00
34179.09%
Cash Flow from Investing Activities
-389
-0.297
-389.00
-130876.43%
Cash Flow from Financing Activities
-1086
-0.168
-1,086.00
-646328.57%
Net Cash Inflow / Outflow
678
-6.812
684.00
10053.02%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-10
0
-10.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 99.91% vs 75.36% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
2,163.00
1,082.00
99.91%